1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nonsteroidal Antiinflammatory Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Nonsteroidal Antiinflammatory Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Injection
1.5 Market by Application
1.5.1 Global Nonsteroidal Antiinflammatory Drugs Market Share by Application: 2021-2026
1.5.2 Osteoarthritis
1.5.3 Muscle Aches
1.5.4 Backaches
1.5.5 Dental Pain
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Nonsteroidal Antiinflammatory Drugs Market
1.8.1 Global Nonsteroidal Antiinflammatory Drugs Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Nonsteroidal Antiinflammatory Drugs Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Nonsteroidal Antiinflammatory Drugs Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Nonsteroidal Antiinflammatory Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nonsteroidal Antiinflammatory Drugs Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Nonsteroidal Antiinflammatory Drugs Sales Volume Market Share by Region (2015-2020)
3.2 Global Nonsteroidal Antiinflammatory Drugs Sales Revenue Market Share by Region (2015-2020)
3.3 North America Nonsteroidal Antiinflammatory Drugs Sales Volume
3.3.1 North America Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.3.2 North America Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Nonsteroidal Antiinflammatory Drugs Sales Volume
3.4.1 East Asia Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume (2015-2020)
3.5.1 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Nonsteroidal Antiinflammatory Drugs Sales Volume (2015-2020)
3.6.1 South Asia Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Volume (2015-2020)
3.7.1 Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume (2015-2020)
3.8.1 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume (2015-2020)
3.9.1 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Nonsteroidal Antiinflammatory Drugs Sales Volume (2015-2020)
3.10.1 Oceania Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Nonsteroidal Antiinflammatory Drugs Sales Volume (2015-2020)
3.11.1 South America Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.11.2 South America Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Nonsteroidal Antiinflammatory Drugs Sales Volume (2015-2020)
3.12.1 Rest of the World Nonsteroidal Antiinflammatory Drugs Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Nonsteroidal Antiinflammatory Drugs Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Nonsteroidal Antiinflammatory Drugs Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Nonsteroidal Antiinflammatory Drugs Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Nonsteroidal Antiinflammatory Drugs Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Nonsteroidal Antiinflammatory Drugs Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Nonsteroidal Antiinflammatory Drugs Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Nonsteroidal Antiinflammatory Drugs Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Nonsteroidal Antiinflammatory Drugs Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Nonsteroidal Antiinflammatory Drugs Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Nonsteroidal Antiinflammatory Drugs Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Nonsteroidal Antiinflammatory Drugs Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Nonsteroidal Antiinflammatory Drugs Sales Volume Market Share by Type (2015-2020)
14.2 Global Nonsteroidal Antiinflammatory Drugs Sales Revenue Market Share by Type (2015-2020)
14.3 Global Nonsteroidal Antiinflammatory Drugs Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Nonsteroidal Antiinflammatory Drugs Consumption Volume by Application (2015-2020)
15.2 Global Nonsteroidal Antiinflammatory Drugs Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Nonsteroidal Antiinflammatory Drugs Business
16.1 Sanofi S.A.
16.1.1 Sanofi S.A. Company Profile
16.1.2 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Product Specification
16.1.3 Sanofi S.A. Nonsteroidal Antiinflammatory Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Pfizer
16.2.1 Pfizer Company Profile
16.2.2 Pfizer Nonsteroidal Antiinflammatory Drugs Product Specification
16.2.3 Pfizer Nonsteroidal Antiinflammatory Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Novartis AG
16.3.1 Novartis AG Company Profile
16.3.2 Novartis AG Nonsteroidal Antiinflammatory Drugs Product Specification
16.3.3 Novartis AG Nonsteroidal Antiinflammatory Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 GlaxoSmithKline PLC
16.4.1 GlaxoSmithKline PLC Company Profile
16.4.2 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Product Specification
16.4.3 GlaxoSmithKline PLC Nonsteroidal Antiinflammatory Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 DOMESCO
16.5.1 DOMESCO Company Profile
16.5.2 DOMESCO Nonsteroidal Antiinflammatory Drugs Product Specification
16.5.3 DOMESCO Nonsteroidal Antiinflammatory Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Nonsteroidal Antiinflammatory Drugs Manufacturing Cost Analysis
17.1 Nonsteroidal Antiinflammatory Drugs Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Nonsteroidal Antiinflammatory Drugs
17.4 Nonsteroidal Antiinflammatory Drugs Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Nonsteroidal Antiinflammatory Drugs Distributors List
18.3 Nonsteroidal Antiinflammatory Drugs Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Nonsteroidal Antiinflammatory Drugs (2021-2026)
20.2 Global Forecasted Revenue of Nonsteroidal Antiinflammatory Drugs (2021-2026)
20.3 Global Forecasted Price of Nonsteroidal Antiinflammatory Drugs (2015-2026)
20.4 Global Forecasted Production of Nonsteroidal Antiinflammatory Drugs by Region (2021-2026)
20.4.1 North America Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.3 Europe Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.7 Africa Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.9 South America Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Nonsteroidal Antiinflammatory Drugs Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
21.2 East Asia Market Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
21.3 Europe Market Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Countriy
21.4 South Asia Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
21.5 Southeast Asia Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
21.6 Middle East Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
21.7 Africa Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
21.8 Oceania Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
21.9 South America Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
21.10 Rest of the world Forecasted Consumption of Nonsteroidal Antiinflammatory Drugs by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer